BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

299 related articles for article (PubMed ID: 18524870)

  • 1. Reduction of hepatic glucocorticoid receptor and hexose-6-phosphate dehydrogenase expression ameliorates diet-induced obesity and insulin resistance in mice.
    Liu Y; Nakagawa Y; Wang Y; Liu L; Du H; Wang W; Ren X; Lutfy K; Friedman TC
    J Mol Endocrinol; 2008 Aug; 41(2):53-64. PubMed ID: 18524870
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Direct regulation of glucose and not insulin on hepatic hexose-6-phosphate dehydrogenase and 11β-hydroxysteroid dehydrogenase type 1.
    Fan Z; Du H; Zhang M; Meng Z; Chen L; Liu Y
    Mol Cell Endocrinol; 2011 Feb; 333(1):62-9. PubMed ID: 21163329
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sub-chronic administration of the 11beta-HSD1 inhibitor, carbenoxolone, improves glucose tolerance and insulin sensitivity in mice with diet-induced obesity.
    Taylor A; Irwin N; McKillop AM; Flatt PR; Gault VA
    Biol Chem; 2008 Apr; 389(4):441-5. PubMed ID: 18225986
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tissue-specific dysregulation of hexose-6-phosphate dehydrogenase and glucose-6-phosphate transporter production in db/db mice as a model of type 2 diabetes.
    Wang Y; Nakagawa Y; Liu L; Wang W; Ren X; Anghel A; Lutfy K; Friedman TC; Liu Y
    Diabetologia; 2011 Feb; 54(2):440-50. PubMed ID: 21052977
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Specific reduction of G6PT may contribute to downregulation of hepatic 11β-HSD1 in diabetic mice.
    Du H; Liu L; Wang Y; Nakagawa Y; Lyzlov A; Lutfy K; Friedman TC; Peng X; Liu Y
    J Mol Endocrinol; 2013 Apr; 50(2):167-78. PubMed ID: 23267038
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Carbenoxolone treatment ameliorated metabolic syndrome in WNIN/Ob obese rats, but induced severe fat loss and glucose intolerance in lean rats.
    Prasad Sakamuri SS; Sukapaka M; Prathipati VK; Nemani H; Putcha UK; Pothana S; Koppala SR; Ponday LR; Acharya V; Veetill GN; Ayyalasomayajula V
    PLoS One; 2012; 7(12):e50216. PubMed ID: 23284633
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 11beta-Hydroxysteroid dehydrogenase type 1 regulates insulin and glucagon secretion in pancreatic islets.
    Swali A; Walker EA; Lavery GG; Tomlinson JW; Stewart PM
    Diabetologia; 2008 Nov; 51(11):2003-11. PubMed ID: 18779947
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The 11β-hydroxysteroid dehydrogenase type 1 inhibitor protects against the insulin resistance and hepatic steatosis in db/db mice.
    Yuan X; Li H; Bai H; Zhao X; Zhang C; Liu H; Zhang Y; Zhao B; Wu Y; Liu J; Xiang Q; Feng B; Chu Y; Huang Y
    Eur J Pharmacol; 2016 Oct; 788():140-151. PubMed ID: 27242185
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 11β-Hydroxysteroid dehydrogenase type 1 shRNA ameliorates glucocorticoid-induced insulin resistance and lipolysis in mouse abdominal adipose tissue.
    Wang Y; Yan C; Liu L; Wang W; Du H; Fan W; Lutfy K; Jiang M; Friedman TC; Liu Y
    Am J Physiol Endocrinol Metab; 2015 Jan; 308(1):E84-95. PubMed ID: 25389364
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Leptin activation of corticosterone production in hepatocytes may contribute to the reversal of obesity and hyperglycemia in leptin-deficient ob/ob mice.
    Liu Y; Nakagawa Y; Wang Y; Li R; Li X; Ohzeki T; Friedman TC
    Diabetes; 2003 Jun; 52(6):1409-16. PubMed ID: 12765951
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transgenic overexpression of hexose-6-phosphate dehydrogenase in adipose tissue causes local glucocorticoid amplification and lipolysis in male mice.
    Wang Y; Liu L; Du H; Nagaoka Y; Fan W; Lutfy K; Friedman TC; Jiang M; Liu Y
    Am J Physiol Endocrinol Metab; 2014 Mar; 306(5):E543-51. PubMed ID: 24381005
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased glucocorticoid receptor and 11{beta}-hydroxysteroid dehydrogenase type 1 expression in hepatocytes may contribute to the phenotype of type 2 diabetes in db/db mice.
    Liu Y; Nakagawa Y; Wang Y; Sakurai R; Tripathi PV; Lutfy K; Friedman TC
    Diabetes; 2005 Jan; 54(1):32-40. PubMed ID: 15616008
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dietary manipulation reveals an unexpected inverse relationship between fat mass and adipose 11β-hydroxysteroid dehydrogenase type 1.
    Man TY; Michailidou Z; Gokcel A; Ramage L; Chapman KE; Kenyon CJ; Seckl JR; Morton NM
    Am J Physiol Endocrinol Metab; 2011 Jun; 300(6):E1076-84. PubMed ID: 21406612
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of 11β-hydroxysteroid dehydrogenase 1 by carbenoxolone affects glucose homeostasis and obesity in db/db mice.
    Dhanesha N; Joharapurkar A; Shah G; Kshirsagar S; Dhote V; Sharma A; Jain M
    Clin Exp Pharmacol Physiol; 2012 Jan; 39(1):69-77. PubMed ID: 22060140
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hexose-6-phosphate dehydrogenase contributes to skeletal muscle homeostasis independent of 11β-hydroxysteroid dehydrogenase type 1.
    Semjonous NM; Sherlock M; Jeyasuria P; Parker KL; Walker EA; Stewart PM; Lavery GG
    Endocrinology; 2011 Jan; 152(1):93-102. PubMed ID: 21106871
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cellular and genetic models of H6PDH and 11β-HSD1 function in skeletal muscle.
    Zielinska AE; Fletcher RS; Sherlock M; Doig CL; Lavery GG
    Cell Biochem Funct; 2017 Jul; 35(5):269-277. PubMed ID: 28749080
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The expression of 11β-HSDs, GR, and H6PDH in subcutaneous adipose tissue from polycystic ovary syndrome subjects.
    Li S; Tao T; Wang L; Mao X; Zheng J; Zhao A; Liu W
    Horm Metab Res; 2013 Oct; 45(11):802-7. PubMed ID: 23979790
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interplay between H6PDH and 11β-HSD1 implicated in the pathogenesis of type 2 diabetes mellitus.
    Yao F; Chen L; Fan Z; Teng F; Zhao Y; Guan F; Zhang M; Liu Y
    Bioorg Med Chem Lett; 2017 Sep; 27(17):4107-4113. PubMed ID: 28751144
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanism of repression of 11β-hydroxysteroid dehydrogenase type 1 by growth hormone in 3T3-L1 adipocytes.
    Muraoka T; Hizuka N; Fukuda I; Ishikawa Y; Ichihara A
    Endocr J; 2014; 61(7):675-82. PubMed ID: 24759003
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lack of adipose-specific hexose-6-phosphate dehydrogenase causes inactivation of adipose glucocorticoids and improves metabolic phenotype in mice.
    Wang J; Wang Y; Liu L; Lutfy K; Friedman TC; Liu Y; Jiang M; Liu Y
    Clin Sci (Lond); 2019 Nov; 133(21):2189-2202. PubMed ID: 31696216
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.